Literature DB >> 27790495

Acute Right Heart Failure in a Patient with Right Heart Thrombus and Pulmonary Thromboembolism.

Mohammad Mostafa Ansari-Ramandi1, Samaneh Ansari-Ramandi2, Nasim Naderi3.   

Abstract

Right Heart Thrombus (RiHT) management is really controversial, and appropriate guidelines are not present for the management. In patients referring with RiHT and Pulmonary Embolism (PE), there are three ways of managing these patients. Out of the three, one is thrombectomy, which is with high risk taking in mind the comorbidities these patients have. The other is using thrombolytic which, in many cases is contraindicated or with high risk. The other less effective way is full anticoagulation. It is really controversial to choose between these ways of management and no clear approach is present. The case presented is a 44-year-old morbid obese male with history of dyspnea on exertion (functional Class II) and foot oedema or the last three months, who was transferred to the emergency department with respiratory distress and hypoxia. Echocardiography was done for the patient which showed moderate Right Ventricular (RV) dysfunction with severe RV enlargement and a severe Tricuspid Regurgitation (TR) with TR gradient of 70mmHg. He also had a semi-mobile large pedunculated mass in favour of a clot in his RV cavity. With the impression of PE heparin was administered to the patient and he was admitted in the coronary care unit. Pulmonary Computed Tomography (CT) angiography showed sub-segmental Pulmonary Thromboendarterectomy (PTE) in the left lung. He had negative cardiac markers and stable vital signs and so full anticoagulation was chosen for his treatment. His clinical course was uneventful and after 10 days of treatment the RV size and function improved significantly. On follow-up after a month he was doing well. Although recent Guidelines of European Society of Cardiology in management of acute PE stated that RiHT, particularly mobile, are associated with a significantly increased early mortality risk in patients with acute PE. Immediate therapy is mandatory, but optimal treatment is controversial in the absence of controlled trials. Thrombolysis and embolectomy are probably both effective while anticoagulation alone seems to be less effective.

Entities:  

Keywords:  Anticoagulation; Management; Pulmonary embolism

Year:  2016        PMID: 27790495      PMCID: PMC5071995          DOI: 10.7860/JCDR/2016/20601.8473

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  6 in total

1.  Treatment of right heart thromboemboli.

Authors:  Peter S Rose; Naresh M Punjabi; David B Pearse
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

2.  Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients.

Authors:  L Chartier; J Béra; M Delomez; P Asseman; J P Beregi; J J Bauchart; H Warembourg; C Théry
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

3.  A recurrent right heart thrombus in a patient with Behçet's disease.

Authors:  I Dincer; R Dandachi; Y Atmaca; C Erol; N Caglar; D Oral
Journal:  Echocardiography       Date:  2001-01       Impact factor: 1.724

4.  The European Cooperative Study on the clinical significance of right heart thrombi. European Working Group on Echocardiography.

Authors: 
Journal:  Eur Heart J       Date:  1989-12       Impact factor: 29.983

5.  Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry.

Authors:  Marcin Koć; Maciej Kostrubiec; Waldemar Elikowski; Nicolas Meneveau; Mareike Lankeit; Stefano Grifoni; Agnieszka Kuch-Wocial; Antoniu Petris; Beata Zaborska; Branislav S Stefanović; Thomas Hugues; Adam Torbicki; Stavros Konstantinides; Piotr Pruszczyk
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

6.  Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry.

Authors:  Adam Torbicki; Nazzareno Galié; Anna Covezzoli; Elisa Rossi; Marisa De Rosa; Samuel Z Goldhaber
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

  6 in total
  1 in total

1.  Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats.

Authors:  Yunshan Cao; Jiyang Song; Shutong Shen; Heling Fu; Xiang Li; Ying Xu; Aqian Wang; Xinli Li; Min Zhang
Journal:  Oncotarget       Date:  2017-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.